Centessa’s $330M IPO among largest on NASDAQ this year 

Entering a market for newly listed biotechs that has given some of its peers a lukewarm reception this quarter, Medicxi-backed Centessa rose modestly in its first trading day, falling short of a double-digit gain after sliding late in the day. Its offering is among the largest this year by a biotech on NASDAQ.

Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA) had climbed as much as 24% during Friday’s session, but ended the day up just $1.75 to $21.75, attaining a market cap of $1.9 billion at close...